Rosuvastatin

Rosuvastatin ATC Code C10AA07 : Cardiovascular system - Lipid modifying agents - Lipid modifying agents, plain - HMG CoA reductase inhibitors - Rosuvastatin
Rosuvastatin
Rosuvastatin
LatinRosuvastatinum
RoutesOral
Pregnancy categoryX
FDA Approval Date2013-08-12
Molecular FormulaC22H28FN3O6S
Molecular Weight481.537623 g/mol
CAS Number287714-41-4
Rosuvastatin 3D

Rosuvastatin list of brand/trade names

  • United States: Crestor
  • United Kingdom: Crestor
  • Germany: Crestor
  • France: Crestor
  • Spain: Crestor and Provisacor
  • Italy: Crestor, Provisacor and Simestat
  • Canada: Crestor, PMS-Rosuvastatin, RAN-Rosuvastatin and Sandoz Rosuvastatin
  • Russia: Crestor, Mertenil, Rosucard, Rosulip, Roxera and Tevastor
  • Australia: Crestor
  • Brazil: Vivacor
  • Netherlands: Cirantan, Crestor, Provisacor and Rosuvastatin AstraZeneca
  • Poland: Actarosin, Arterios, Crestor, Crosuvo, Ridlip, Romazic, Rosucard, Rosugen, Rosuvastatin Aurobindo, Rosuvastatin Krka, Rosuvastatin Pfizer, Rosuvastatin Ranbaxy, Rosuvastatin Teva, Rosuvastin Medana, Roswera, Surval, Suvardio, Tintaros, Uwatin, Zahron and Zaranta
  • Belgium: Crestor
  • Denmark: Crestor
  • Finland: Crestor and Rosuvastatin Krka
  • Greece: Crestor
  • India: Akroz, Bestor, Fortius, Jprest, Novastat, Razel, Rolistat, Rosat, Rosevast, Rosidoc, Rosta, Rostar, Rosulex, Rosulip, Rosumac, Rosuvas, Rosytab, Rovastat, Rozuone, Rozustat and Zyrova
  • Ireland: Crestor and Rosuvastatin Mylan
  • Norway: Crestor
  • Portugal: Bessesist, Crestor, Rosuvastatina Actavis, Rosuvastatina Aurobindo, Rosuvastatina Doc Generici, Rosuvastatina Hexal, Rosuvastatina Labesfal, Rosuvastatina Parke-Davis, Rosuvastatina Ratiopharm, Rosuvastatina Sandoz, Rosuvastatina Sigillata, Rosuvastatina Teclave, Rosuvastatina Teva, Tilvissot, Toruvass and Visacor
  • Sweden: Crestor
  • Switzerland: Crestor
  • Indonesia: Crestor
  • Turkey: Colnar, Crelix, Crestor, Kolros, Livercol, Nolip, Reakt, Rosact, Rosava, Rosucor, Rosufix, Rosuvas, Stage, Stata and Ultrox


ATC Codes

  1. Alimentary tract and metabolisma
  2. Blood and blood forming organs
  3. Cardiovascular system
  4. Dermatological drugs
  5. Genitourinary system and reproductive hormones
  6. Systemic hormonal preparations
  7. Antiinfectives for systemic use
  8. Antineoplastic and immunomodulating agents
  9. Musculoskeletal system
  10. Nervous system
  11. Antiparasitic products, insecticides and repellents
  12. Respiratory system
  13. Sensory organs
  14. Various ATC structures

The newly added categories

  1. Givosiran
  2. Volanesorsen
  3. Casimersen
  4. Zanubrutinib
  5. Tivozanib
  6. Fedratinib
  7. Tucatinib
  8. Everolimus
  9. Abemaciclib
  10. Selumetinib